Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 4/20 | 0.56 |
| ▸ | HTT | P42858 | 2/20 | 0.56 |
| ▸ | ABCC4 | O15439 | 1/20 | 0.56 |
| ▸ | GAA | P10253 | 1/20 | 0.56 |
| ▸ | TSHR | P16473 | 1/20 | 0.56 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.56 |
| ▸ | MEN1 | O00255 | 3/20 | 0.56 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.56 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.51 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.51 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.51 |
| ▸ | CA2 | P00918 | 1/20 | 0.48 |
| ▸ | NPC1 | O15118 | 1/20 | 0.48 |
| ▸ | HPGD | P15428 | 1/20 | 0.48 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.48 |
| ▸ | STAT1 | P42224 | 1/20 | 0.48 |
| ▸ | RAB9A | P51151 | 1/20 | 0.48 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.48 |
| ▸ | RELA | Q04206 | 1/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Pyridine SCHEMBL639564 | 0.89 | GAA (0.50) | GAAMEN1KMT2ACA2ALDH1A1 | |
| SCHEMBL1395755 | 0.89 | LMNA (0.69) | LMNAHTTABCC4GAATSHR | |
| Hydrochloric Acid SCHEMBL21382514 | 0.87 | LMNA (0.67) | LMNAHTTABCC4GAATSHR | |
| SCHEMBL28103661 | 0.85 | CYP17A1 (0.56) | LMNAMEN1KMT2ASMN1; SMN2CA2 | |
| SCHEMBL13492969 | 0.85 | MKNK1 (0.63) | LMNAHTTCA2ALDH1A1 | |
| Acetone SCHEMBL11103575 | 0.84 | LMNA (0.62) | LMNAHTTABCC4GAATSHR | |
| Pyrimidine SCHEMBL28153109 | 0.80 | CA2 (0.48) | GAAMEN1KMT2ACA2ALDH1A1 | |
| SCHEMBL1177086 | 0.78 | CA2 (0.48) | LMNAMEN1KMT2ASLC6A2SLC6A3 | |
| Methyl Alcohol SCHEMBL12487135 | 0.77 | CES2 (0.58) | TSHRMEN1KMT2ACA2 | |
| SCHEMBL1178369 | 0.77 | CA2 (0.58) | GAASMN1; SMN2CA2RAB9AKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20130116211-A1 | Novel Salts Of Boswellic Acids And Selectively Enriched Boswellic Acids And Processes For The Same | GOKARAJU GANGA RAJU (IN) | 2013-05-09 | — | — | US | claimed |
| US-20090042832-A1 | NOVEL SALTS OF BOSWELLIC ACIDS AND SELECTIVELY ENRICHED BOSWELLIC ACIDS AND PROCESSES FOR THE SAME | LAILA IMPEX (IN) | 2009-02-12 | — | — | US | claimed |
| US-20130116211-A1 | Novel Salts Of Boswellic Acids And Selectively Enriched Boswellic Acids And Processes For The Same | GOKARAJU GANGA RAJU (IN) | 2013-05-09 | — | — | US | disclosed |
| US-20090042832-A1 | NOVEL SALTS OF BOSWELLIC ACIDS AND SELECTIVELY ENRICHED BOSWELLIC ACIDS AND PROCESSES FOR THE SAME | LAILA IMPEX (IN) | 2009-02-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090042832-A1 | NOVEL SALTS OF BOSWELLIC ACIDS AND SELECTIVELY ENRICHED BOSWELLIC ACIDS AND PROCESSES FOR THE SAME | OGA, KAT2B, AADAT | LMNA 2900/4885HTT 2448/4885ABCC4 2399/4885 |
| US-20130116211-A1 | Novel Salts Of Boswellic Acids And Selectively Enriched Boswellic Acids And Processes For The Same | OGA, KAT2B, AADAT | LMNA 2777/4885HTT 2400/4885ABCC4 2398/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.